Acceptance rate:
Time to first decision with review:
44 days*
Time from acceptance to publication:
24 days*
Impact Factor (JCR):
Total content views:

Aims and scope

Stroke and Vascular Neurology is the official journal of the Chinese Stroke Association. Supported by a team of renowned Editors, and fully open access, the journal encourages debate on controversial techniques, issues on health policy and social medicine.
Stroke and Vascular Neurology will appeal to clinical stroke neurologists, neurosurgeons and basic neuroscientists. It will consider submissions of clinical and translational original research, short reports, editorials, and reviews to improve patient care.


Stroke and Vascular Neurology is published by BMJ on behalf of the Chinese Stroke Association. Chinese Stroke Association (CSA) is an academic nonprofit professional organisation dedicated to stroke prevention, therapy, rehabilitation, research, quality of care and education. CSA represents all who are involved in this area of work. CSA held its inaugural national congress in Beijing on January 18, 2015, marking the establishment of the one and only national organization in the field of cerebrovascular disease. The mission of CSA is to unite and organize the professionals and volunteers of academic, scientific and public sectors to work together to promote the scientific research and reduce stroke incidence, disability and mortality. CSA will also promote and facilitate international collaboration and establishment of the Chinese model of multidisciplinary approach for prevention and control of stroke. Chinese Stroke Association Building 6, Zone 3, Advanced Business Park (ABP), 188 South 4th Ring West Road, Fengtai District, Beijing, China. 100070.

Editorial board

For information about the Stroke and Vascular Neurology editorial team, please refer to the Editorial Board page.

Journal information

Publication Model
Open access
Launch date
Digital Archives
Indexed by
Web of Science Core Collection: Science Citation Index Expanded, Current Contents: Clinical Medicine, Medline (Index Medicus), PubMed Central, Scopus, Embase (Excerpta Medica), DOAJ, Google Scholar
Peer review model
Double anonymised; both the reviewer and the author are anonymous to each other.
Print ISSN
Online ISSN

Journal Statistics 2023

Acceptance rate: 12% Speed Time to first decision with review: 44 days (median) Time to first decision without review: 4 days (median) Time from acceptance to publication: 24 days (median)
Impact Impact Factor category: Clinical Neurology
Impact Factor (JCR): 5.9 Impact Factor rank: 29/212 5 year Impact Factor: 7.3 Journal Citation Indicator: 1.61 Eigenfactor: 0.00438 Citescore: 10.2 Citescore rank: 34/373 Scimago Journal Rank (SJR): 1.735
Reach Total content views: 164,118 Total Altmetric mentions: 597
DORA logo
The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure. How we get these metrics


COPE logo
The BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
Equator network logo
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting accurate, transparent reporting of research studies. The BMJ Group is a sponsor of its activities.
AllTrials logo
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.